Tsung‐Ying Yang

2.5k total citations
20 papers, 752 citations indexed

About

Tsung‐Ying Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tsung‐Ying Yang has authored 20 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Tsung‐Ying Yang's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Tsung‐Ying Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Tsung‐Ying Yang collaborates with scholars based in Taiwan, United States and Japan. Tsung‐Ying Yang's co-authors include Gee‐Chen Chang, Kun‐Chieh Chen, Shih-Lan Hsu, Ho Lin, Mei-Chih Chen, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Mong‐Hong Lee, Liem Phan and Chih‐Yi Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Tsung‐Ying Yang

19 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsung‐Ying Yang Taiwan 12 364 313 269 139 124 20 752
James Turnbull United States 10 265 0.7× 517 1.7× 312 1.2× 313 2.3× 54 0.4× 27 870
Jeremy McGuire United States 10 320 0.9× 188 0.6× 111 0.4× 257 1.8× 52 0.4× 20 740
Milena Rondón‐Lagos Colombia 14 333 0.9× 183 0.6× 158 0.6× 246 1.8× 76 0.6× 41 720
Rongrong Ge United States 13 470 1.3× 286 0.9× 125 0.5× 169 1.2× 25 0.2× 17 695
Zuzana Bencokova France 12 604 1.7× 276 0.9× 138 0.5× 365 2.6× 39 0.3× 14 911
Carolyn Waugh Kinkade United States 11 578 1.6× 202 0.6× 273 1.0× 184 1.3× 44 0.4× 18 944
Takuro Kometani Japan 16 555 1.5× 624 2.0× 600 2.2× 178 1.3× 48 0.4× 43 1.2k
Clay E.S. Comstock United States 18 735 2.0× 363 1.2× 451 1.7× 290 2.1× 55 0.4× 22 1.2k
Chao Lü China 19 567 1.6× 198 0.6× 149 0.6× 332 2.4× 65 0.5× 49 1.0k
Shaheen Khan United States 12 236 0.6× 394 1.3× 146 0.5× 63 0.5× 54 0.4× 26 988

Countries citing papers authored by Tsung‐Ying Yang

Since Specialization
Citations

This map shows the geographic impact of Tsung‐Ying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Ying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Ying Yang more than expected).

Fields of papers citing papers by Tsung‐Ying Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Ying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Ying Yang. The network helps show where Tsung‐Ying Yang may publish in the future.

Co-authorship network of co-authors of Tsung‐Ying Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Ying Yang. A scholar is included among the top collaborators of Tsung‐Ying Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Ying Yang. Tsung‐Ying Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, I‐Chieh, Yi‐Ming Chen, Hui‐Wen Yang, Jeng‐Sen Tseng, & Tsung‐Ying Yang. (2025). Interplay of Polygenic Risk Score, Smoking Statuses, and Air Pollution on Lung Adenocarcinoma Risk in a Taiwanese Population. Respirology. 30(4). 317–325.
2.
Waqar, Saiama N., Kristof Cuppens, Rosario García Campelo, et al.. (2025). First-line (1L) datopotamab deruxtecan (Dato-DXd) + rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5).. Journal of Clinical Oncology. 43(16_suppl). 8521–8521. 2 indexed citations
3.
Yang, Tsung‐Ying, et al.. (2024). Association of Wild-Type TP53 with Downregulation of Lovastatin Sensitivity in Human Non-Small Cell Lung Cancer Cells. Current Issues in Molecular Biology. 46(9). 10130–10139. 2 indexed citations
4.
5.
Hsu, Kuo-Hsuan, Jing-Wen Huang, Jeng‐Sen Tseng, et al.. (2021). Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients. OncoTargets and Therapy. Volume 14. 2139–2148. 11 indexed citations
6.
Wu, Chih‐Ying, Chih-Liang Wang, Tsung‐Ying Yang, et al.. (2020). Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study. Journal of the Formosan Medical Association. 120(2). 874–882. 1 indexed citations
7.
Lin, Eugene, Mei-Chih Chen, G. M. Shazzad Hossain Prince, et al.. (2019). Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications. International Journal of Molecular Sciences. 20(16). 3881–3881. 23 indexed citations
8.
Tseng, Chien‐Hua, Ben‐Jei Tsuang, Chun‐Ju Chiang, et al.. (2019). The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan. Journal of Thoracic Oncology. 14(5). 784–792. 139 indexed citations
9.
Lin, Ho, Mei‐Chih Chen, G. M. Shazzad Hossain Prince, & Tsung‐Ying Yang. (2019). Mechanistic insight of cyclin-dependent kinase 5 in modulating lung cancer growth. The Chinese Journal of Physiology. 62(6). 231–231. 10 indexed citations
10.
Lee, Ming-Yang, et al.. (2018). Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis. Cancer Management and Research. Volume 10. 2835–2848. 8 indexed citations
11.
Chang, Gee‐Chen, Chien‐Hua Tseng, Kuo-Hsuan Hsu, et al.. (2016). Predictive factors for EGFR -tyrosine kinase inhibitor retreatment in patients with EGFR -mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study. Lung Cancer. 104. 58–64. 20 indexed citations
12.
Hsu, Kuo-Hsuan, Jeng‐Sen Tseng, Chih-Liang Wang, et al.. (2016). Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients. Oncotarget. 7(33). 53299–53308. 6 indexed citations
13.
Tseng, Jeng‐Sen, Chih-Liang Wang, Tsung‐Ying Yang, et al.. (2015). Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma. Lung Cancer. 90(3). 472–476. 13 indexed citations
14.
Chen, Mei-Chih, Shih-Lan Hsu, Ho Lin, & Tsung‐Ying Yang. (2014). Retinoic acid and cancer treatment. Biomedicine. 4(4). 22–22. 80 indexed citations
15.
Yang, Tsung‐Ying, Chang-Tze Ricky Yu, Liem Phan, et al.. (2012). p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle. 11(18). 3433–3442. 45 indexed citations
16.
Velázquez-Torres, Guermarie, Ji-Hyun Shin, Enrique Fuentes‐Mattei, et al.. (2012). Aurora B kinase phosphorylates and instigates degradation of p53. Proceedings of the National Academy of Sciences. 109(24). E1513–22. 143 indexed citations
17.
Yang, Shi‐Yi, Tsung‐Ying Yang, Kun‐Chieh Chen, et al.. (2011). EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients. Clinical Cancer Research. 17(8). 2149–2158. 26 indexed citations
18.
Hsu, Kuo-Hsuan, Kun‐Chieh Chen, Tsung‐Ying Yang, et al.. (2011). Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns. Journal of Thoracic Oncology. 6(6). 1066–1072. 42 indexed citations
19.
Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations
20.
Yang, James Chih‐Hsin, Jin‐Yuan Shih, Kun‐Chieh Chen, et al.. (2006). Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer. Cancer. 107(8). 1873–1882. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Turnbull Breakdown of academic impact, for papers by Jeremy McGuire Breakdown of academic impact, for papers by Milena Rondón‐Lagos Breakdown of academic impact, for papers by Rongrong Ge Breakdown of academic impact, for papers by Zuzana Bencokova Breakdown of academic impact, for papers by Carolyn Waugh Kinkade Breakdown of academic impact, for papers by Takuro Kometani Breakdown of academic impact, for papers by Clay E.S. Comstock Breakdown of academic impact, for papers by Chao Lü Breakdown of academic impact, for papers by Shaheen Khan
Rankless by CCL
2026